About University Clinical Trials Inc.
Clinical Trials at University Clinical Trials Inc.
During the past decade, University Clinical Trials Inc. conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 17 clinical trials were completed, i.e. on
average, 85% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 11 clinical trials were completed. i.e. 137.5%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University Clinical Trials Inc." #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "LEO Pharma" with 5 trials
sponsored, "Dermira, Inc." with 3 trials sponsored, "Alfasigma S.p.A." with 1 trials sponsored and "Amgen"
with 1 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University Clinical Trials Inc."
#1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Prosoft Clinical" with 1 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at University Clinical Trials Inc.
According to Clinical.Site data, the most researched conditions in "University Clinical Trials Inc." are
"Atopic Dermatitis" (7 trials), "Acne Vulgaris" (4 trials), "Plaque Psoriasis" (4 trials), "Actinic Keratosis" (2 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "University Clinical Trials Inc." in a lesser frequency.
Clinical Trials Intervention Types at University Clinical Trials Inc.
Most popular intervention types in "University Clinical Trials Inc." are "Drug" (24 trials), "Other" (6 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Baricitinib" (3 trials), "Vehicle" (3 trials), "Ixekizumab" (2 trials) and "LEO 90100" (2 trials). Other intervention names were less common.
Clinical Trials Genders at University Clinical Trials Inc.
The vast majority of trials in "University Clinical Trials Inc." are
27 trials for "All" genders.
Clinical Trials Status at University Clinical Trials Inc.
Currently, there are NaN active trials in "University Clinical Trials Inc.".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 20 completed trials in University Clinical Trials Inc.,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in University Clinical Trials Inc., 1 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".